688505.SH
复旦张江
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 8.38
−3.01%Aug 14, 2026, 10:32 UTC
Fudan Zhangjiang Bio-Pharmaceutical reported interim results for the six months ended June 2026, with net profit of 36.895 million RMB, up 545% year-on-year.